Regulus Therap (RGLS) Reports Q3 Loss of $15.98

Regulus Therap (NASDAQ: RGLS) reported Q3 EPS of ($15.98), versus ($11.68) reported last year. Revenue for the quarter came in at $2.8 million, versus $3.81 million reported last year.

For earnings history and earnings-related data on Regulus Therap (RGLS) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Berenberg Starts Lloyds TSB Group (LYG) at Hold, 'shares are fairly valued'
• Uxin Limited (UXIN) Tops Q3 EPS by 49c; offers outlook
• European stocks mixed; Euro banking sector, Meta Platforms in the spotlight